Table 2.
Assessment of metabolic syndrome parameters in psoriasis patients and controls
| Parameter | Psoriasis | Control group | P-value | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| N | x | SD | Min. | Max. | N | x | SD | Min. | Max. | ||
| TG | 246 | 145.68 | 29.95 | 77 | 210 | 75 | 110.92 | 28.83 | 35 | 155 | < 0.00001 |
| HDL | 246 | 58.74 | 14.56 | 38 | 116 | 75 | 58.17 | 13.49 | 43 | 104 | * |
| Fasting glucose | 246 | 96.71 | 16.02 | 66 | 135 | 75 | 92.64 | 13.17 | 66 | 115 | 0.046 |
| Waist circum.: | 246 | 97.03 | 13.71 | 65 | 138 | 75 | 92.00 | 14.42 | 62 | 120 | 0.006 |
| Female | 108 | 95.00 | 14.14 | 65 | 126 | 45 | 91.2 | 16.35 | 62 | 120 | * |
| Male | 138 | 99.04 | 1.87 | 72 | 138 | 30 | 93.2 | 11.67 | 70 | 120 | 0.023 |
| WHR: | 246 | 0.9 | 0.12 | 69.00 | 1.19 | 75 | 0.87 | 0.08 | 0.73 | 1.04 | 0.043 |
| Female | 108 | 0.87 | 0.1 | 0.69 | 1.1 | 45 | 0.87 | 0.069 | 0.75 | 0.97 | * |
| Male | 138 | 0.93 | 0.13 | 0.7 | 1.19 | 30 | 0.88 | 0.1 | 0.73 | 1.04 | 0.049 |
| Systolic BP | 246 | 135.06 | 12.82 | 115 | 165 | 75 | 128.8 | 9.6 | 110 | 140 | 0.0001 |
| Diastolic BP | 246 | 83.26 | 6.16 | 70 | 90 | 75 | 83.00 | 6.92 | 70 | 90 | * |
TG – triglycerides, HDL – high-density lipoprotein, Waist circum. – waist circumference, WHR – waist to hip ratio, BP – blood pressure, SD – standard deviation.
*
If not specified: p > 0.05.